Our Vision
To build the world's most connected clinical research ecosystem by enabling collaboration, innovation and operational excellence across regions, therapeutic areas and healthcare disciplines.
Connect · Clinical Development Network
The Clinical Development Network is the global collaboration platform within the Guosa Life Sciences ecosystem, connecting investigators, research institutions, sponsors, healthcare organizations, governments, industry partners and communities to accelerate clinical development, scientific innovation and global health.
About the Network
A coordinated platform, not a directory.
The Clinical Development Network (CDN) is a global clinical development ecosystem established by Guosa Life Sciences to coordinate collaboration among qualified investigators, research institutions, healthcare organizations, academic partners, industry and global health stakeholders.
Rather than operating as a public directory of investigators or research sites, the CDN functions as a coordinated platform that brings together qualified institutions and subject-matter expertise to facilitate collaboration, strengthen operational consistency and support sponsors, investigators, governments and global health organizations engaged in clinical research.
To build the world's most connected clinical research ecosystem by enabling collaboration, innovation and operational excellence across regions, therapeutic areas and healthcare disciplines.
To connect people, institutions, expertise and opportunities through a globally integrated network that accelerates the development of innovative medicines, vaccines, diagnostics, medical devices and digital health technologies.
Why the Network Exists
Clinical research capability is expanding through scientific capacity, healthcare infrastructure, regulatory advancement and growing investment in research and innovation. Yet while many institutions have developed significant expertise, opportunities remain to strengthen coordination, promote consistency, facilitate multi-country collaboration and support efficient study implementation across diverse healthcare systems.
The CDN addresses these opportunities by providing a collaborative framework that connects qualified institutions and expertise while supporting operational excellence, research quality and sustainable capacity development. It complements regional initiatives promoting regulatory convergence and harmonization, helping participating organizations prepare for increasingly integrated multi-country clinical research.
Who the Network Serves
How the Network Is Organized
The CDN is the umbrella for a portfolio of regional, therapeutic, functional and scientific Centers of Excellence. Each Center concentrates expertise in a priority discipline while drawing on the wider Network.
The Africa-focused Center of Excellence for early-phase clinical research, translational medicine, vaccine innovation and epidemic preparedness.
Visit our AE-PCRN PortalQualified cancer centers, investigators and laboratories connected into one sponsor-ready oncology network supporting Phase I–IV research.
Explore OncologyVaccine development and immunization research, from early-phase studies through large field efficacy trials and epidemic preparedness.
Explore VaccinesWhat GLS Provides
Coordination is the outcome, not the service. GLS operates the network as a working platform, and this is what sponsors and participating organizations actually receive.
Standing governance bodies with defined decision rights and formal qualification of institutions and investigators against one standard, reviewed annually.
One ICH GCP-aligned quality system across the network: SOPs, training, deviations and CAPA, audit and continuous inspection readiness. Monitoring is centralized, not delegated.
One protocol interpretation, one set of SOPs, one training standard and one data model, so quality does not vary by country or site.
Centralized feasibility and realistic enrollment modeling, a single master contract and budgets negotiated once rather than country by country.
Country-by-country submissions coordinated centrally, with medical monitoring, expedited safety reporting and defined escalation.
Cold-chain, IP distribution and permits; data integrity and privacy standards; and investigator development through GLS Academy.
One feasibility process, one contract, one budget, one quality system and one accountable partner.
Matched opportunities, qualification against a recognized standard and capacity development, while retaining full independence.
Matched opportunities, credential support, professional development and a coordinated route to sponsors.
Our Guiding Principles
Supporting high-quality research through experienced investigators, qualified institutions and internationally recognized standards.
Facilitating partnerships among investigators, institutions, governments, industry, sponsors and global health organizations.
Promoting Good Clinical Practice, robust quality management, continuous improvement and operational consistency.
Supporting ethical conduct, regulatory compliance, transparency and accountability.
Strengthening institutional capability, professional development and long-term sustainability.
Encouraging new technologies, scientific approaches and operational models that improve efficiency and quality.
Network Coordination
Coordination here means operating the network, not administering it. GLS qualifies the sites, owns the quality system, runs feasibility, holds the contracts and budgets, coordinates regulatory and safety and is accountable to the sponsor for delivery.
Participating institutions retain full independence over their operations, scientific activities and contractual arrangements. GLS provides the connective infrastructure that makes a distributed network behave like a single, sponsor-ready platform.
Register your interest and our Network team will guide you through qualification.